Singapore markets close in 5 hours 40 minutes

Biophytis SA (6XB.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.8800+0.8778 (+39,900.00%)
At close: 08:10AM CEST
Full screen
Previous close0.0022
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0022 - 0.8800
52-week range0.0022 - 8.6000
Avg. volume2
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings date08 Apr 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Benzinga

    Why Is Penny Stock Biophytis Trading Higher On Tuesday?

    Monday, Biophytis SA (NASDAQ:BPTS) announced the launch of a new clinical development program named OBA, with BIO101 (20-hydroxyecdysone) as a potential treatment for obesity combined with GLP-1 receptor agonists. The OBA Phase 2 clinical study is expected to start in mid-2024, upon regulatory approvals, with the first patients expected to be treated in the second half of 2024. BIO101 (20-hydroxyecdysone) will be evaluated in obese patients treated with GLP-1 RAs and following hypocaloric dietin

  • Zacks

    Biophytis (BPTS) to Begin Phase II Obesity Study, Stock Up

    Biophytis (BPTS) rises in the after-market hours as it announces the launch of a new clinical development program for its investigational candidate, BIO101, to treat obesity in combination with GLP-1 drugs.

  • Insider Monkey

    40 Cities with the Lowest Life Expectancy in the US

    In this article, we look at 40 cities with the lowest life expectancy in the US. You can skip our section on developments in the pharmaceutical and biotech industries to enhance longevity and head over directly to 10 Cities with the Lowest Life Expectancy in the US. Average lifespan in the US climbed from just […]